OCTANT INC
Emeryville, CA · Founded 2013 · CIK 0001628721 · Biotech · Private
Proposal and task order management software for government contractors
octant.bio →- Grants
- $811K
- 3 awards
- Sector median: 1
- Raised
- $145K
- 1 Form D · Dec 2014
- 142 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 3 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $145,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Functional Genomics of G Protein-Coupled Receptors | $246,943 | |
| Federal grant | Department of Health and Human Services · Phase I · Functional Genomics of G Protein-Coupled Receptors | $246,943 | |
| Federal grant | Department of Health and Human Services · Phase I · High-throughput chemical screens for GPCR functional selectivity | $316,638 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2939 | Barricade Therapeutics Corp | — | $100K |
| 2940 | Surf Bucket, Inc | — | $10K |
| 2941 | DISCO Pharmaceuticals | — | — |
| 2942 | OCTANT INC | — | $145K |
| 2943 | JASTLabs Corp | — | $50M |
| 2944 | Rayaldee | — | — |
| 2945 | EPITUNE LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert AndradeDirector · Executive Officer · Promoter
- Maurice CostantiniDirector · Executive Officer · Promoter
Patents
- Pharmacological Correctors Of Rhodopsin And Uses Thereofgranted
- Pharmacological Correctors Of Rhodopsin And Uses Thereofapplication
- Systems And Methods For Measuring Cell Signaling Protein Activitygranted
- Pathogen Diagnostic Testapplication
- Quality Control For Reporter Screening Assaysapplication
- Pathogen Diagnostic Testgranted
- Systems And Methods For Measuring Cell Signaling Protein Activityapplication
- Transcriptional Relay Systemapplication
- Systems For Protein-protein Interaction Screeningapplication
- Systems And Methods For Utilizing A Plasma Membrane Anchored Proteaseapplication
- Nanoscale High-throughput Chemistry Screenapplication
- Methods And Systems For Identifying Functional Sitesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.